The DESTINY clinical research study is looking for participants 18 years of age or older who are diagnosed with hypereosinophilic syndrome (HES) and have a history of 2 or more flares within the past 12 months. Study doctors are testing an investigational drug given as injections to find out if it works compared to a placebo and to determine the investigational drug’s safety in people living with HES.
If you qualify, you will be involved with the study for approximately 60 weeks (a little over 1 year).
There are rules in place to help protect the rights, safety, and well-being of people who volunteer for research studies. These rules are put in place to make sure studies follow strict scientific and ethical guidelines. Before a clinical research study can begin, a review board must review the study. This group is called an IRB or institutional review board, and is made up of doctors, scientists, and members of the community.
Taking part in this study is totally voluntary and you may stop at any time for any reason. Additionally, you do not have to pay for the study treatment, study supplies, or tests that are part of the DESTINY study.
Before new treatments and medications are made available to the public, they first have to be studied to make sure they’re safe and effective. That’s where research studies come in. A research study, or clinical trial, is a type of medical research that’s used to determine how well a new treatment or medication will work. The goal is simple: To help doctors find safe and effective ways to treat, diagnose or even prevent all kinds of medical conditions.Learn More
If you’re interested in learning more about the DESTINY study, including potential risks and benefits of participation, you can find additional details at CTGOV.